APEX 1.1 screened 19.3 million peptide fragments from 2,897 prion-related proteins and identified 1,179 candidate antimicrobial peptides, termed prionins. Among 75 synthesized candidates, 59 inhibited at least one tested bacterial strain; two selected peptides reduced Acinetobacter baumannii burden in a mouse skin-abscess model. The study shows that prion-related sequences can yield experimentally active antimicrobial fragments, but does not show that these peptides are naturally released or function as host-defense agents in their source organisms.
Technology: APEX 1.1 deep-learning antimicrobial-peptide prediction and prioritization
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Of 75 synthesized APEX-selected prionins, 59 inhibited at least one bacterial strain in vitro; two selected peptides reduced A. baumannii burden in a mouse skin-abscess model.
- Still unknown: No evidence shows these fragments are naturally released from their source proteins or physiologically function as host-defense peptides in native organisms. Mouse results do not establish human efficacy or safety.
- AI role: APEX 1.1 scored peptide fragments for predicted antimicrobial activity and prioritized candidates from a search across prion-related proteins for synthesis and experimental screening.
Evidence sources: https://www.nature.com/articles/s41564-026-02408-1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary Nature Microbiology full text as indexed, including methods, results, author contributions and affiliations..
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
The APEX deep-learning model screened 16,123 venom proteins by generating and scoring 40,626,260 venom-encrypted peptides. After activity prediction and filtering for low similarity to known antimicrobial peptides, the authors selected 58 for experiments; 53 showed antimicrobial activity against at least one tested pathogen. Three selected peptides reduced bacterial counts after topical treatment in a mouse Acinetobacter baumannii skin-abscess model; the wolf-spider-derived Arachnoserver-5 peptide produced a reported three-log reduction versus untreated controls through day four, without significant body-weight change under the study conditions.
Technology: APEX deep-learning model for bacterial strain-specific minimum inhibitory concentration prediction
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: After activity prediction and filtering for low similarity to known antimicrobial peptides, the authors selected 58 for experiments; 53 showed antimicrobial activity against at least one tested pathogen.
- Still unknown: Only 58 of the 386 low-similarity candidates were experimentally tested, and activity was measured against a defined panel of 11 strains; some tested peptides were cytotoxic. The mouse study was a topical single-dose skin-abscess model with six animals per group, not systemic treatment or human efficacy. The paper notes possible ion-channel activity for many candidates and calls for follow-up safety testing. A related APEX study mined archaeal proteomes (10.1038/s41564-025-02061-0); this entry is limited to the separate venom-protein source library and its distinct peptide set and experiments.
- AI role: APEX scored 40.6 million candidate peptide fragments generated from venom proteins for predicted antimicrobial activity. The authors filtered predicted hits for sequence dissimilarity to known antimicrobial peptides, synthesized a selected subset, and experimentally tested antimicrobial activity, cytotoxicity and selected animal-model efficacy. The AI model narrowed an otherwise very large peptide search space; assays established which selected candidates were active.
Evidence sources: https://www.nature.com/articles/s41467-025-60051-6.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 61 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
ApexGO uses Bayesian optimization with a peptide variational autoencoder and an activity-prediction oracle to optimize derivatives of ten peptide templates. The primary article reports 100 synthesized sequences tested in vitro and activity improvements; selected candidates showed activity in mouse A. baumannii infection models. These results are preclinical and do not establish human efficacy.
Technology: ApexGO; peptide variational autoencoder; Bayesian optimization; APEX predictor
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The primary source reports the study-specific result summarized here.
- Still unknown: Independent replication and broad deployment are not established by this review.
- AI role: A predictor scores generated peptide derivatives and Bayesian optimization uses feedback to propose variants; researchers synthesize and test them in vitro and in mouse models.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13201158/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: Primary-source indexed article or abstract and bibliographic metadata reviewed; complete source scope is given in source_checks..
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
Machine learning identified 863,498 candidate sequences in microbial genomes and metagenomes. Of 100 synthesized peptides, 63 inhibited at least one of the eleven strains tested; some showed activity in animal models. The catalog contains candidates, not hundreds of thousands of clinically validated antibiotics.
Technology: Machine learning for antimicrobial peptides
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: 100 predicted peptides were synthesized and tested in vitro and in vivo against drug-resistant pathogens and human gut commensals; 63 inhibited pathogens.
- Still unknown: The abstract states no limitations and does not name the strains or animal models used.
- AI role: Machine learning predicted antimicrobial peptides across 63,410 metagenomes and 87,920 genomes, producing a catalog of 863,498 non-redundant candidates.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1016/j.cell.2024.05.013&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 477 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
AI analysis of proteins from extinct hominins identified sequences that were then synthesized and tested against pathogens in culture and in mice. Some peptides showed antimicrobial activity; these are preclinical results, with no demonstration of safety or efficacy in humans.
Technology: AI for molecular de-extinction
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Fragments were tested for antimicrobial activity in vitro, and representative fragments reduced A. baumannii infection in mouse skin abscess and thigh infection models.
- Still unknown: The abstract does not explicitly state limitations; the findings rest on in vitro work and two mouse models rather than human trials.
- AI role: A random forest model (panCleave) predicted protease cleavage sites across proteomes to find antimicrobial fragments in modern human and extinct hominin proteins.
Evidence sources: https://www.engineering.upenn.edu/stories/for-a-new-generation-of-antibiotics-scientists-are-bringing-extinct-molecules-back-to-life-and-discovering-the-hidden-genetics-of-immunity-along-the-way/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1016/j.chom.2023.07.001&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 165 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.